These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 3619584)

  • 1. [Long-term hypertransaminasemia disclosing a muscular disease].
    Odièvre M; Rivron M; Landrieu P
    Arch Fr Pediatr; 1987; 44(6):453-4. PubMed ID: 3619584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of administration of phosphocreatine on the clinical, biochemical and electromyographic evolution of Duchenne's progressive muscular dystrophy].
    Radu H; Keresztes L; Stenzel K
    Minerva Med; 1968 Dec; 59(99):5524-9. PubMed ID: 5718841
    [No Abstract]   [Full Text] [Related]  

  • 3. [Progressive musclar dystrophy in the experience of the Pediatric Clinic of Florence. Longitudinal study of 43 subjects].
    Adami Lami Conti C; Calandi C; Nistri R; Aulisi A; Bucciolini MG; Vannelli G; Ragazzini F
    Minerva Pediatr; 1981 May; 33(9):385-412. PubMed ID: 7019663
    [No Abstract]   [Full Text] [Related]  

  • 4. [Progressive muscle dystrophy. II. Enzyme activity chages in serum in progressive muscle dystrophy].
    Lujf A; Sluga E; Moser K
    Wien Klin Wochenschr; 1971 Feb; 83(7):109-13. PubMed ID: 5547427
    [No Abstract]   [Full Text] [Related]  

  • 5. [Progressive muscular dystrophy: CPK, LDH, ALD (aldolase)--EMG, ECG in patients and their families].
    Diotallevi P; Bargilli E; Danni M; Dellantonio R; Tocchini M; Milani-Comparetti M
    Boll Soc Ital Biol Sper; 1988 Jun; 64(6):523-30. PubMed ID: 3190905
    [No Abstract]   [Full Text] [Related]  

  • 6. [Plasmatic enzyme studies in individuals with progressive muscular dystrophy in the course of various therapeutic trials].
    Mancini G; Lapi AS; Schwarzenberg TL; Canibus R; Natoli V
    Arch Ital Pediatr Pueric; 1968; 26(1):36-46. PubMed ID: 5737311
    [No Abstract]   [Full Text] [Related]  

  • 7. Biochemical aspects of genetically determined progressive muscular dystrophies.
    Luca N; Haţegan D
    Rev Roum Neurol; 1973; 10(6):531-7. PubMed ID: 4771091
    [No Abstract]   [Full Text] [Related]  

  • 8. [Serum enzyme activities in progressive muscular dystrophy].
    Yano I; Furukawa Y; Masaki H; Tani J
    Nihon Rinsho; 1966 Mar; 24(3):571-5. PubMed ID: 6007312
    [No Abstract]   [Full Text] [Related]  

  • 9. Slowly progressive X-linked recessive muscular dystrophy (type 3b). Report of cases and review of the literature.
    Zellweger H; Hanson JW
    Arch Intern Med; 1967 Nov; 120(5):525-35. PubMed ID: 6054585
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical experimental studies of the activity of a cellular extract (TRF). 3. Activity in muscular diseases].
    Del Giudice E; De Luca R; Del Prete A; Sepe O; Federico P; Portone N; Spagnoletti G
    Boll Soc Ital Biol Sper; 1968 Nov; 44(22):1868-71. PubMed ID: 5735735
    [No Abstract]   [Full Text] [Related]  

  • 11. [Serum enzyme activities in the families of patients with progressive muscular dystrophy].
    Tani J; Yano I; Masaki H; Fukuyama K; Saeki B
    Iryo; 1967 Jul; 21(7):848-53. PubMed ID: 5582480
    [No Abstract]   [Full Text] [Related]  

  • 12. [Enzymatic activity of the serum in the family of a progressive muscular dystrophy patient].
    Esaki K; Tokoro T; Yamamoto K; Kato T; Asano B
    Iryo; 1969 Oct; 23(10):1306-11. PubMed ID: 5364982
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on enzymatic activity in serum obtained from muscular dystrophic patients.
    Yamaji K; Imai H; Esaki K; Tokoro T; Hotta K
    Nagoya Med J; 1968 Apr; 14(1):55-64. PubMed ID: 5696330
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evaluation of serum pyruvate kinase in patients with Duchenne's muscular dystrophy and carriers. Comparison with other enzyme determinations].
    Calandi C; Adami Lami C; Guidotti T; Nistri R; Papuzza S; Tozzi P; Poggi G
    Minerva Pediatr; 1981 May; 33(10):453-64. PubMed ID: 7254147
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of drug administration on the child with progressive muscular dystrophy].
    Nakahara T; Annaka S; Baba T; Kanno M
    Iryo; 1969 Oct; 23(10):1319-27. PubMed ID: 5364983
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative study of the enzyme activity of muscle tissue of normal children and children with progressive muscular dystrophy at different stages of the disease].
    Hooft C; De Laey P; Lambert Y
    Rev Fr Etud Clin Biol; 1966 May; 11(5):510-1. PubMed ID: 5938397
    [No Abstract]   [Full Text] [Related]  

  • 17. [Proceedings: Enzymology of the muscular myelopathic atrophies: enzymologic and ultrastructural study on Charcot-Marie-Tooth disease].
    Rizzoli AA
    Quad Sclavo Diagn; 1973 Mar; 9(1):166-75. PubMed ID: 4788705
    [No Abstract]   [Full Text] [Related]  

  • 18. [Serum aldolase and creatine phosphokinase in progressive muscular dystrophy].
    Ceccarelli A; Leone P
    Clin Pediatr (Bologna); 1967 May; 49(5):237-45. PubMed ID: 6080497
    [No Abstract]   [Full Text] [Related]  

  • 19. [Plasma level of hemopexin (Hpx) in families with progressive muscular dystrophy (PMD)].
    Diotallevi P; Balducci E; Canapa A; Danni M; Giamagli CA; Lucesoli S; Ravaglia P; Milani-Comparetti M
    Boll Soc Ital Biol Sper; 1988 Jun; 64(6):531-8. PubMed ID: 3190906
    [No Abstract]   [Full Text] [Related]  

  • 20. [Histological, serum enzyme and electromyographic studies in thyreomyopathies in children (research on hypothroid patients)].
    Iafusco F; Canani MB; Granata E
    Pediatria (Napoli); 1967 Dec; 75(6):893-913. PubMed ID: 5617794
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.